0001209191-19-028674.txt : 20190510
0001209191-19-028674.hdr.sgml : 20190510
20190510073926
ACCESSION NUMBER: 0001209191-19-028674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190508
FILED AS OF DATE: 20190510
DATE AS OF CHANGE: 20190510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peters Richard
CENTRAL INDEX KEY: 0001697628
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35409
FILM NUMBER: 19812865
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERRIMACK PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001274792
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-441-1000
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-08
0
0001274792
MERRIMACK PHARMACEUTICALS INC
MACK
0001697628
Peters Richard
C/O MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201
CAMBRIDGE
MA
02139
1
1
0
0
President and CEO
Stock Option (right to buy)
10.74
2019-05-08
4
J
0
25000
0.00
D
2028-02-14
Common Stock
25000
200000
D
Stock Option (right to buy)
4.15
2019-05-08
4
J
0
225000
0.00
D
2028-12-10
Common Stock
225000
0
D
An option to purchase 225,000 shares was originally granted to the Reporting Person on February 15, 2018. 25,000 shares underlying this option were rescinded on May 8, 2019.
This option vested as to 1/12th of the total number of shares originally granted on 5/15/18 and an additional 1/12th of the total number of shares originally granted at the end of each successive three month period thereafter until 2/15/21.
An option to purchase 225,000 shares was originally granted to the Reporting Person on December 11, 2018. This option was rescinded in full on May 8, 2019.
The original vesting schedule for this option was 1/12th of the total number of shares granted on 3/11/19 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 12/11/21.
/s/ Brian J. Kickham, attorney-in-fact
2019-05-10